What does PERT stand for?

Pancreatic Enzyme Replacement Therapy

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Personnel Support Personnel Status Personnel Status Report Personnel Status Report Personnel Status Report Personnel Tempo Personnel Support Detachment (US Navy) Personnel Support Activity Personnel Support Activity Detachment Personnel to Vehicles Schedule Product		Parallel Element Reliability Test Performance Evaluation and Review Technique Physical Education & Recreational Training Pi Eta Research Technology (Pi Eta Consulting Company; Singapore) Pilot Emissions Reduction Trading Project (Canada) Portfolio Evaluation and Review Technique (less common; probably incorrect) Prison Emergency Response Team Problem & Enhancement Review Team (Sprint) Process Engineering Review Team Professional Emergency Response Team

Samples in periodicals archive:

Discussion FCP generally presents in young CF patients within 12 months of starting high-dose pancreatic enzyme replacement therapy.

Fibrosing colonopathy in an adult cystic fibrosis patient after ...

Data were collected through the hospital-based clinic approximately six months apart, before and after implementation of the Australian Pancreatic Enzyme Replacement Therapy Guidelines.

Original research; pancreatic enzyme replacement therapy: adherence ...

This appointment reflects Alnara's continued growth as the company prepares to submit a new drug application (NDA) and bring to market liprotamase, a novel, oral, non-porcine pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).

Alnara Pharmaceuticals Announces Appointment of Lee R. Brettman, ...

Altus' Trizytek Phase 3 clinical program is the largest ever conducted to evaluate the efficacy and safety of pancreatic enzyme replacement therapy in cystic fibrosis patients.

Altus Pharmaceuticals Announces Presentation of Phase 3 Trizytek ...

Altus' Trizytek Phase 3 clinical program is the largest ever conducted to evaluate the efficacy and safety of pancreatic enzyme replacement therapy in cystic fibrosis patients.

Altus Pharmaceuticals Announces Achievement of Primary Endpoint in ...

Altus expects to recruit approximately 300 patients from more than 50 sites worldwide for the two trials, making this Phase III program the largest ever conducted to evaluate the efficacy and safety of pancreatic enzyme replacement therapy in cystic fibrosis patients.

Altus Pharmaceuticals Reacquires European Development and ...

Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 ...